Characterizing effects of age, sex and psychosis symptoms on thalamocortical functional connectivity in youth.
Adolescent
Age Factors
Cerebral Cortex
/ physiopathology
Child
Female
Humans
Magnetic Resonance Imaging
Male
Nerve Net
Neural Pathways
/ physiopathology
Philadelphia
Prefrontal Cortex
/ physiopathology
Psychotic Disorders
/ physiopathology
Pulvinar
/ physiopathology
Schizophrenia
/ physiopathology
Sensorimotor Cortex
/ physiopathology
Sex Characteristics
Thalamus
/ physiopathology
Young Adult
Adolescence
Development
Psychosis spectrum
Resting state
Thalamocortical connectivity
Thalamus
Journal
NeuroImage
ISSN: 1095-9572
Titre abrégé: Neuroimage
Pays: United States
ID NLM: 9215515
Informations de publication
Date de publication:
11 2021
11 2021
Historique:
received:
30
03
2021
revised:
29
07
2021
accepted:
06
09
2021
pubmed:
11
9
2021
medline:
22
1
2022
entrez:
10
9
2021
Statut:
ppublish
Résumé
The thalamus is composed of multiple nuclei densely connected with the cortex in an organized manner, forming parallel thalamocortical networks critical to sensory, motor, and cognitive functioning. Thalamocortical circuit dysfunction has been implicated in multiple neurodevelopmental disorders, including schizophrenia, which also often exhibit sex differences in prevalence, clinical characteristics, and neuropathology. However, very little is known about developmental and sex effects on thalamocortical networks in youth. The present study characterized the effects of age, sex and psychosis symptomatology in anatomically constrained thalamocortical networks in a large community sample of youth (n = 1100, aged 8-21) from the Philadelphia Neurodevelopmental Cohort (PNC). Cortical functional connectivity of seven anatomically defined thalamic nuclear groups were examined: anterior, mediodorsal, ventral lateral, ventral posterolateral, pulvinar, medial and lateral geniculate nuclear groups. Age and sex effects were characterized using complementary thalamic region-of-interest (ROI) to cortical ROI and voxel-wise analyses. Effects of clinical symptomatology were analyzed by separating youth into three groups based on their clinical symptoms; typically developing youth (n = 298), psychosis spectrum youth (n = 320), and youth with other psychopathologies (n = 482). As an exploratory analysis, association with PRIME scores were used as a dimensional measure of psychopathology. Age effects were broadly characterized by decreasing connectivity with sensory/motor cortical areas, and increasing connectivity with heteromodal prefrontal and parietal cortical areas. This pattern was most pronounced for thalamic motor and sensory nuclei. Females showed greater connectivity between multiple thalamic nuclear groups and the visual cortex compared to males, while males showed greater connectivity with the inferior frontal and orbitofrontal cortices. Youth with psychosis spectrum symptoms showed a subtle decrease in thalamic connectivity with the premotor and prefrontal cortices. Across all youth, greater PRIME scores were associated with lower connectivity between the prefrontal cortex and mediodorsal thalamus. By characterizing typical development in anatomically constrained thalamocortical networks, this study provides an anchor for conceptualizing disruptions to the integrity of these networks observed in neurodevelopmental disorders.
Identifiants
pubmed: 34506914
pii: S1053-8119(21)00835-1
doi: 10.1016/j.neuroimage.2021.118562
pmc: PMC10021021
mid: NIHMS1748168
pii:
doi:
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
118562Subventions
Organisme : NIMH NIH HHS
ID : R01 MH102266
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH115000
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH123563
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000445
Pays : United States
Informations de copyright
Copyright © 2021. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of Competing Interest No commercial support was received for the preparation of this manuscript. AA consults, holds equity and is a scientific board member for BlackThorn Therapeutics. All other authors have no conflicts of interest to report.
Références
Brain Cogn. 2004 Jun;55(1):11-29
pubmed: 15134840
Neuroreport. 2009 Jul 1;20(10):930-5
pubmed: 19562831
Psychiatry Res. 2000 Dec 22;100(3):129-38
pubmed: 11120440
Cereb Cortex. 2014 Dec;24(12):3116-30
pubmed: 23825317
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Brain. 2013 Jun;136(Pt 6):1942-55
pubmed: 23739917
Schizophr Res. 2017 Feb;180:58-63
pubmed: 27531067
Brain Struct Funct. 2015 Mar;220(2):1173-86
pubmed: 24469153
Neuroscientist. 2012 Oct;18(5):502-15
pubmed: 21636849
Schizophr Res. 2020 Dec;226:147-157
pubmed: 31147286
Am J Psychiatry. 1998 Mar;155(3):434-6
pubmed: 9501761
Clin Psychol Sci. 2018 Sep 1;6(5):721-734
pubmed: 30319928
Am J Psychiatry. 2020 Dec 1;177(12):1159-1167
pubmed: 32911995
J Neurosci. 2017 Jun 7;37(23):5594-5607
pubmed: 28450543
PLoS One. 2017 Nov 29;12(11):e0188511
pubmed: 29186161
Brain Lang. 2000 Sep;74(2):157-70
pubmed: 10950912
Schizophr Res. 2019 Aug;210:270-277
pubmed: 30630706
Nature. 2017 May 11;545(7653):219-223
pubmed: 28467827
JAMA Psychiatry. 2016 Dec 01;73(12):1239-1248
pubmed: 27806157
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Nov;2(8):696-705
pubmed: 29202110
Biol Psychiatry. 2015 Mar 1;77(5):445-53
pubmed: 24813335
Nat Neurosci. 2003 Jul;6(7):750-7
pubmed: 12808459
Dev Cogn Neurosci. 2018 Aug;32:43-54
pubmed: 29567376
Science. 2012 Aug 10;337(6095):753-6
pubmed: 22879517
Schizophr Bull. 2017 May 1;43(3):601-610
pubmed: 27559077
Neuroimage. 2010 Oct 15;53(1):303-17
pubmed: 20600998
Mol Psychiatry. 2016 Apr;21(4):547-53
pubmed: 26033243
Biol Psychiatry. 2016 Jun 15;79(12):1016-25
pubmed: 26248537
Behav Brain Res. 2013 Feb 1;238:95-108
pubmed: 23078950
Am J Psychiatry. 2009 Aug;166(8):863-74
pubmed: 19411370
Am J Psychiatry. 2012 Oct;169(10):1092-9
pubmed: 23032387
Neuron. 2016 Jan 6;89(1):209-20
pubmed: 26748092
Proc Natl Acad Sci U S A. 2021 Jul 13;118(28):
pubmed: 34260385
Schizophr Bull. 1997;23(3):483-501
pubmed: 9327511
Nat Neurosci. 2017 Jul;20(7):987-996
pubmed: 28481349
Front Syst Neurosci. 2010 May 18;4:10
pubmed: 20514143
J Neural Transm (Vienna). 2006 Jul;113(7):907-28
pubmed: 16252070
Neuroimage. 2018 Dec;183:314-326
pubmed: 30121337
Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Oct;4(10):859-869
pubmed: 31202821
J Neurosci Res. 2017 Jan 2;95(1-2):617-625
pubmed: 27870438
Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):12574-12579
pubmed: 27791099
Biol Psychiatry Cogn Neurosci Neuroimaging. 2017 Jan;2(1):76-84
pubmed: 28584881
Neuron. 2013 Mar 20;77(6):1151-62
pubmed: 23522049
Schizophr Bull. 1998;24(2):203-18
pubmed: 9613621
Eur Neuropsychopharmacol. 2019 Apr;29(4):519-528
pubmed: 30770234
Am J Psychiatry. 2013 Sep;170(9):1011-9
pubmed: 24030612
AJNR Am J Neuroradiol. 2008 Nov;29(10):1883-9
pubmed: 18784212
Nat Neurosci. 2018 Dec;21(12):1753-1763
pubmed: 30455456
PLoS Biol. 2015 Dec 29;13(12):e1002328
pubmed: 26713863
J Digit Imaging. 2018 Jun;31(3):304-314
pubmed: 29725960
Neuroimage. 2016 Jan 1;124(Pt B):1097-1101
pubmed: 25988229
J Neurosci. 2007 Feb 7;27(6):1356-64
pubmed: 17287510
Dev Psychopathol. 2000 Summer;12(3):501-27
pubmed: 11014750
Nature. 2015 Oct 29;526(7575):705-9
pubmed: 26503050
Neuroimage. 2014 Jan 1;84:290-8
pubmed: 24004695
J Neurosci. 2014 Jul 2;34(27):9067-75
pubmed: 24990927
Int J Psychophysiol. 2013 May;88(2):136-42
pubmed: 23501018
World Psychiatry. 2014 Oct;13(3):296-305
pubmed: 25273303
Curr Top Behav Neurosci. 2010;4:509-28
pubmed: 21312411
Trends Cogn Sci. 2017 Aug;21(8):589-599
pubmed: 28578977
Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Aug;7(8):782-792
pubmed: 34655804
Neuroimage. 2020 Dec;223:117361
pubmed: 32919055
Arch Gen Psychiatry. 2009 Aug;66(8):811-22
pubmed: 19652121
Neuron. 2002 Jan 31;33(3):341-55
pubmed: 11832223
J Neurosci. 2020 Feb 5;40(6):1265-1275
pubmed: 31896669
Neuroimage. 2010 Jan 15;49(2):1911-8
pubmed: 19761851
Neuropsychopharmacology. 2019 Aug;44(9):1649-1658
pubmed: 31060043
Psychiatry Res. 2012 Aug-Sep;203(2-3):111-25
pubmed: 22981426
J Cogn Neurosci. 2018 Feb;30(2):144-159
pubmed: 28984526
Curr Top Behav Neurosci. 2010;4:555-83
pubmed: 21312413
Cereb Cortex. 2005 Jan;15(1):31-9
pubmed: 15238447
Neuron. 2017 Nov 15;96(4):736-754
pubmed: 29144973
Neurosci Biobehav Rev. 2015 Jul;54:57-75
pubmed: 25616183
Front Psychiatry. 2012 Jan 25;3:2
pubmed: 22291667
Cereb Cortex. 2015 Sep;25(9):2919-28
pubmed: 24812084
Brain Cogn. 2004 Jun;55(1):134-47
pubmed: 15134848
JAMA Psychiatry. 2015 Sep;72(9):882-91
pubmed: 26267151